Transcript apt.rcpsych.org
Suggested guidelines for managing cardiovascular risk prior to and during treatment with acetylcholinesterase inhibitors in Alzheimer’s disease. bpm, heartbeats per minute; the ‘drug’ means the chosen AChE inhibitor. Jeremy P. Rowland et al. APT 2007;13:178-184 ©2007 by The Royal College of Psychiatrists